These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 28471826)

  • 1. Chronic comorbidities associated with inflammatory bowel disease: prevalence and impact on healthcare costs in Switzerland.
    Bähler C; Schoepfer AM; Vavricka SR; Brüngger B; Reich O
    Eur J Gastroenterol Hepatol; 2017 Aug; 29(8):916-925. PubMed ID: 28471826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in prevalence, mortality, health care utilization and health care costs of Swiss IBD patients: a claims data based study of the years 2010, 2012 and 2014.
    Bähler C; Vavricka SR; Schoepfer AM; Brüngger B; Reich O
    BMC Gastroenterol; 2017 Dec; 17(1):138. PubMed ID: 29197335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare utilization and comorbidity burden among children and young adults in the United States with systemic lupus erythematosus or inflammatory bowel disease.
    Karve S; Candrilli S; Kappelman MD; Tolleson-Rinehart S; Tennis P; Andrews E
    J Pediatr; 2012 Oct; 161(4):662-670.e2. PubMed ID: 22578787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in health-care costs and utilization for inflammatory bowel disease from 2010 to 2014 in Korea: A nationwide population-based study.
    Kim JW; Lee CK; Rhee SY; Oh CH; Shim JJ; Kim HJ
    J Gastroenterol Hepatol; 2018 Apr; 33(4):847-854. PubMed ID: 29055148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aging on healthcare costs of inflammatory bowel disease: a glimpse into the future.
    van der Have M; Mangen MJ; van der Valk ME; Smeets HM; van Bodegraven A; Dijkstra G; Fidder HH; de Jong DJ; Pierik M; Ponsioen CY; van der Meulen-de Jong AE; van der Woude CJ; van de Meeberg PC; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; Bolwerk CJ; Vermeijden JR; Siersema PD; Leenders M; Oldenburg B; ;
    Inflamm Bowel Dis; 2014 Apr; 20(4):637-45. PubMed ID: 24518606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology and socio-economic aspects of chronic inflammatory bowel diseases in Switzerland].
    Schoepfer A; Safroneeva E
    Ther Umsch; 2019 Jan; 75(5):255-259. PubMed ID: 30700239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
    Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Cost Analysis in a Population-based Inception Cohort of Inflammatory Bowel Disease Patients in the First Year of Diagnosis.
    Niewiadomski O; Studd C; Hair C; Wilson J; McNeill J; Knight R; Prewett E; Dabkowski P; Dowling D; Alexander S; Allen B; Tacey M; Connell W; Desmond P; Bell S
    J Crohns Colitis; 2015 Nov; 9(11):988-96. PubMed ID: 26129692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does the hospital cost of care differ for inflammatory bowel disease patients with or without gastrointestinal infections? A case-control study].
    Schmidt C; Köhler F; Kräplin T; Hartmann M; Lerch MM; Stallmach A
    Z Gastroenterol; 2014 Jul; 52(7):643-8. PubMed ID: 25026005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-hospital burden of hidradenitis suppurativa in patients with inflammatory bowel disease: a decade nationwide analysis from 2004 to 2014.
    Ramos-Rodriguez AJ; Timerman D; Khan A; Bonomo L; Hunjan MK; Lemor A
    Int J Dermatol; 2018 May; 57(5):547-552. PubMed ID: 29431201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The health care cost of intravenous iron treatment in IBD patients depends on the economic evaluation perspective.
    Bager P; Dahlerup JF
    J Crohns Colitis; 2010 Oct; 4(4):427-30. PubMed ID: 21122539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of patients with anemia in selected diseases.
    Ershler WB; Chen K; Reyes EB; Dubois R
    Value Health; 2005; 8(6):629-38. PubMed ID: 16283863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis.
    Mak LY; Ng SC; Wong IOL; Li MKK; Lo FH; Wong MTL; Leung CM; Tsang SWC; Chan KH; Sze SF; Shan EHS; Lam BCY; Hui AJ; Hung IFN; Leung WK
    J Gastroenterol Hepatol; 2018 Jan; 33(1):141-149. PubMed ID: 28475813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of outpatient care in patients with inflammatory bowel disease in a German University Hospital.
    Ebinger M; Leidl R; Thomas S; Von Tirpitz C; Reinshagen M; Adler G; Konig HH
    J Gastroenterol Hepatol; 2004 Feb; 19(2):192-9. PubMed ID: 14731130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease.
    Sack C; Phan VA; Grafton R; Holtmann G; van Langenberg DR; Brett K; Clark M; Andrews JM
    J Crohns Colitis; 2012 Apr; 6(3):302-10. PubMed ID: 22405166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory Bowel Disease and the Risk of Autoimmune Diseases.
    Wilson JC; Furlano RI; Jick SS; Meier CR
    J Crohns Colitis; 2016 Feb; 10(2):186-93. PubMed ID: 26507860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opioid Use Is Associated With Higher Health Care Costs and Emergency Encounters in Inflammatory Bowel Disease.
    Alley K; Singla A; Afzali A
    Inflamm Bowel Dis; 2019 Nov; 25(12):1990-1995. PubMed ID: 31087042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Costs of ambulant care for patients with inflammatory bowel disease in general practice].
    Beiche A; König HH; Ebinger M; Matysiak-Klose D; Braun V; Leidl R
    Z Gastroenterol; 2003 Jun; 41(6):527-36. PubMed ID: 12806538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High end of life health care costs and hospitalization burden in inflammatory bowel disease patients: A population-based study.
    Murthy SK; James PD; Antonova L; Chalifoux M; Tanuseputro P
    PLoS One; 2017; 12(5):e0177211. PubMed ID: 28498877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease.
    Haapamäki J; Roine RP; Turunen U; Färkkilä MA; Arkkila PE
    J Crohns Colitis; 2011 Feb; 5(1):41-7. PubMed ID: 21272803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.